Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Complarate vs Actemra in Rheumatoid Arthritis
NCT06475508Phase 3Completed
- Sponsor
- Generium
- Start
- Feb 2023
- Primary completion
- Jan 2024
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Generium. Started Feb 2023; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06475508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06475508.